{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:03Z","timestamp":1790390643644,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neuropharm.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T03:31:10Z","timestamp":1473391870000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome"],"prefix":"10.1016","volume":"111","author":[{"given":"C\u00e9sar","family":"Quiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Gulyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Ruiqian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.09.002_bib1","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sleep.2009.03.007","article-title":"Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib3","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1212\/WNL.0b013e318294b3f6","article-title":"Thalamic glutamate\/glutamine in restless legs syndrome: increased and related to disturbed sleep","volume":"80","author":"Allen","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-005-0173-6","article-title":"A\u00a0detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors","volume":"183","author":"Antoniou","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pbb.2013.10.030","article-title":"Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model","volume":"118","author":"Bleickardt","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1523\/JNEUROSCI.2942-08.2009","article-title":"Control and function of the homeostatic sleep response by adenosine A1 receptors","volume":"29","author":"Bjorness","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib7","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1523\/JNEUROSCI.3906-15.2016","article-title":"An adenosine-mediated glial-neuronal circuit for homeostatic sleep","volume":"36","author":"Bjorness","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib8","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1507704112","article-title":"Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer","volume":"112","author":"Bonaventura","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib9","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Franco, R. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib10","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.sleep.2006.07.002","article-title":"The effects of dietary iron deprivation on murine circadian sleep architecture","volume":"7","author":"Dean","year":"2006","journal-title":"Sleep. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom Disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2008.12.056","article-title":"Sleep deprivation increases A(1) adenosine receptor density in the rat brain","volume":"1258","author":"Elmenhorst","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib15","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1523\/JNEUROSCI.5066-06.2007","article-title":"Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study","volume":"27","author":"Elmenhorst","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0091-3057(01)00563-9","article-title":"Iron deficiency decreases dopamine D1 and D2 receptors in rat brain","volume":"69","author":"Erikson","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","article-title":"Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors","volume":"6","author":"Ferr\u00e9","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J.\u00a0Neurochem."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2016.09.002_bib20","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3233\/JAD-2010-1400","article-title":"Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine","volume":"20","author":"Ferr\u00e9","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2015.05.028","article-title":"Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer","volume":"104","author":"Ferr\u00e9","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.5665\/sleep.3934","article-title":"Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome","volume":"37","author":"Ferri","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib23","first-page":"919","article-title":"An evidence-based analysis of the association between periodic leg movements during sleep and arousals in restless legs syndrome","volume":"38","author":"Ferri","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5665\/sleep.3558","article-title":"Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome","volume":"37","author":"Garcia-Borreguero","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2008.10.007","article-title":"Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells","volume":"215","author":"Gulyani","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib26","first-page":"1","article-title":"Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats","volume":"6","author":"Han","year":"2003","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib27","doi-asserted-by":"crossref","first-page":"20130594","DOI":"10.1098\/rstb.2013.0594","article-title":"Astrocytic adenosine: from synapses to psychiatric disorders","volume":"369","author":"Hines","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1460-9568.2003.02747.x","article-title":"Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos","volume":"18","author":"Karcz-Kubicha","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.5665\/sleep.1890","article-title":"Decoupling of sleepiness from sleep time and intensity during chronic sleep restriction: evidence for a role of the adenosine system","volume":"35","author":"Kim","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jsr.12300","article-title":"Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain","volume":"24","author":"Kim","year":"2015","journal-title":"J.\u00a0Sleep. Res."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.sleep.2004.04.004","article-title":"Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS","volume":"5","author":"Kushida","year":"2004","journal-title":"Sleep. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000014542","article-title":"Regulation of transferrin function and expression: review and update","volume":"7","author":"Lok","year":"1998","journal-title":"Biol. Signals Recept."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.sleep.2007.03.005","article-title":"Neurobiology of REM and NREM sleep","volume":"8","author":"McCarley","year":"2007","journal-title":"Sleep. Med."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib34","doi-asserted-by":"crossref","first-page":"e16088","DOI":"10.1371\/journal.pone.0016088","article-title":"Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists","volume":"6","author":"Orru","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.09.002_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3940(96)13143-8","article-title":"Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents","volume":"218","author":"Popoli","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1046\/j.1471-4159.2003.02245.x","article-title":"Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure","volume":"88","author":"Quarta","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.expneurol.2010.04.004","article-title":"Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and corticostriatal neurotransmission","volume":"224","author":"Quiroz","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib39","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/mds.25576","article-title":"Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging","volume":"28","author":"Rizzo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","article-title":"Adenosine receptors and the central nervous system","volume":"193","author":"Sebasti\u00e3o","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib42","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3945\/jn.108.095224","article-title":"Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue","volume":"138","author":"Unger","year":"2008","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2016.09.002_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.4111-08.2009","article-title":"Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal","volume":"29","author":"Van Dort","year":"2009","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630377X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630377X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T18:51:34Z","timestamp":1536432694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081630377X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":43,"alternative-id":["S002839081630377X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}